Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 16,000 shares at $28.25 ($453K) on 2014-09-12, disclosed to the SEC on 2014-09-12.
Scheduled sale ($453k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.35 | 8,000 | $227K | 50.1% |
| 2 | $28.25 | 8,000 | $226K | 49.9% |
| Total | $28.30 avg | 16,000 | $453K | 100% |
| Filing → |
| SGNT | SELL | 2014-10-08 | $505K | — | Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-08-29 | $435K | — | Filing → |